Dmytro Kharkov

Fulgent Genetics targets wider engagement at APG2026 San Diego exhibit fair

Fulgent Genetics targets wider engagement at APG2026 San Diego exhibit fair
Fulgent Genetics joins APG2026 event

Fulgent Genetics announced its participation in the APG2026 Exhibit Fair and Strolling Dinner, scheduled for Thursday, May 28 from 6:00 to 9:00 PM in San Diego.

The company aims to connect with stakeholders and industry professionals during the event, spotlighting its comprehensive genetic testing and services described as having 'everything under the sea.' Fulgent Genetics continues to prioritize engagement at key industry gatherings. Details on product launches or service demonstrations at the event have not been specified. Details are being clarified.

Fulgent Genetics recently expanded its infertility testing panels to include over 140 genes for females and 160 for males, offering broader coverage in fertility diagnostics earlier this year. The company is also preparing to present data on its nano-encapsulated anti-tumor drug FID-007 at the ASCO meeting later this year. Both initiatives reflect Fulgent's continued development of its genetic testing and therapeutic pipeline.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.